The authorised ANDA is a therapeutic equivalent of the reference-listed drug (RLD), Corlanor tablets, in the same 5 mg and ...

The combined cGMP inspection and pre-licensing inspection (PLI), which took place between July 15 and July 26, 2024, is the ...

Pharma player Granules India Limited on Friday said it has received an Establishment Inspection Report (EIR) from the US Food ...

Indian drugmaker Zydus Lifesciences reported a 14% rise in second-quarter profit on Tuesday, helped by strong demand for generic drugs in its key United States and Indian markets.

The Food and Drug Administration first approved the injectable medication for treating diabetes in 2017; the agency approved a drug with a higher dose of the active ingredient in Ozempic, called ...

Cipla’s FDA-compliant facilities and its investments in US-based units place it in a strong position to weather potential ...

Opening higher at ₹575.95 apiece on the BSE, shares of Granules India Ltd. rose further to touch an intraday high of ₹590.

Granules India announced that it has received an establishment inspection report (EIR) from the U.S. Food and Drug Administration (USFDA) for its Unit V facility located at Jawaharlal Nehru Pharma ...

Ghosh makes visible the moral double standards prevalent in social discourses, especially regarding trading and profiting ...

Goa minister Vishwajit Rane on Saturday asked top officials of departments under him to file police complaints over alleged forged appointment and offer letters. The directive came after Goa Congress ...

All these stations have met the rigorous requirements outlined by FSSAI, ensuring that all food business operators have been ...